COVID-19 Vaccination Prioritization on the Basis of Cardiovascular Risk Factors and Number Needed to Vaccinate to Prevent Death

The supply limitations of COVID-19 vaccines have led to the need to prioritize vaccine distribution. Obesity, diabetes, and hypertension have been associated with an increased risk of severe COVID-19 infection. Approximately half as many individuals with a cardiovascular risk factor need to be vacci...

Full description

Saved in:

Bibliographic Details
Published in:	Canadian journal of cardiology Vol. 37; no. 7; pp. 1112 - 1116
Main Authors:	Leong, Darryl P., Banerjee, Amitava, Yusuf, Salim
Format:	Journal Article
Language:	English
Published:	Elsevier Inc 01.07.2021 Canadian Cardiovascular Society. Published by Elsevier Inc
Subjects:	Brief Rapid Report
ISSN:	0828-282X, 1916-7075, 1916-7075
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The supply limitations of COVID-19 vaccines have led to the need to prioritize vaccine distribution. Obesity, diabetes, and hypertension have been associated with an increased risk of severe COVID-19 infection. Approximately half as many individuals with a cardiovascular risk factor need to be vaccinated against COVID-19 to prevent related death compared with individuals without a risk factor. Adults with body mass index ≥ 30, diabetes, or hypertension should be of a similar priority for COVID-19 vaccination to adults 10 years older with a body mass index of 20 to < 30, no diabetes, and no hypertension. Les limitations d'approvisionnement en vaccins contre la COVID-19 ont abouti à la nécessité d'établir des priorités dans la distribution des vaccins. L'obésité, le diabète et l'hypertension ont été associés à un risque accru d'infection grave par la COVID-19. Il y a approximativement deux fois moins d'individus présentant un facteur de risque cardiovasculaire qui devraient être vaccinés contre la COVID-19 pour prévenir les décès liés à cette maladie, par rapport au nombre d'individus sans facteur de risque. Les adultes ayant un indice de masse corporelle ≥ 30, un diabète ou une hypertension devraient bénéficier d'une priorité de vaccination contre la COVID-19 comparable à celle d'adultes 10 ans plus vieux et ayant un indice de masse corporelle de 20 à < 30, sans diabète et sans hypertension.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0828-282X 1916-7075 1916-7075
DOI:	10.1016/j.cjca.2021.04.012